Theravance Biopharma Logo

Theravance Biopharma

🇺🇸
TBPH
KYG8807B1068

Theravance Biopharma is a US-based biopharmaceutical company specializing in the development of innovative medicines. The company focuses on researching targeted therapies for the treatment of serious respiratory and inflammatory diseases through the use of advanced pharmaceutical compounds.

Next Quarterly Earnings

Tuesday, November 10, 2026
CW 46
Pre-Market
In 75 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 13, 2026

Stock Price

Frequently asked questions

When will Theravance Biopharma report its next quarterly earnings?

Theravance Biopharma is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Theravance Biopharma last report quarterly earnings?

Theravance Biopharma last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at -0.11 USD.

How often has Theravance Biopharma beaten expectations?

Theravance Biopharma has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).

How do I add the Theravance Biopharma earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:$0.24
Actual:
Q2 2026
Missed
Estimate:$0.07
Actual:-$0.11
Difference:-$0.18
Price reaction (1 day):-0.1 %
Price reaction (7 days):-0.1 %
Q1 2026
Missed
Estimate:$0.03
Actual:-$0.10
Difference:-$0.13
Price reaction (1 day):+0.5 %
Price reaction (7 days):-2.5 %
Q3 2025
Beat
Estimate:$0.01
Actual:$0.06
Difference:+$0.05
Q2 2025
Beat
Estimate:-$0.05
Actual:$0.04
Difference:+$0.09
Q1 2025
Beat
Estimate:-$0.13
Actual:-$0.08
Difference:+$0.04

Earnings statistics

Estimates vs. results

3/5
Quarters above estimates
60%
Beat rate
-139.2%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Theravance Biopharma
Ticker Symbol
TBPH
ISIN
KYG8807B1068
Country
🇺🇸
USA
Sector